1/It is helpful to see a review of the concerns raised by professionals & patients prior to the publication of the 2016 CDC Opioid Prescribing Guideline - take a look. I will add highlights from my 2016 docket submission. Nearly all issues re-emerged in published research
2/My own 2016 submission to CDC’s docket was- as is appropriate- respectful of authorial expertise and good intentions.

But my top line concerns were 4.

1/Inappropriately broad conclusions derived from untestable propositions

stefankertesz.medium.com/considering-cd…
2/ CDC’s Dose-related recommendations prioritized *relative* risk over *absolute* risk, and minimized consideration of interaction of risk and protective factors -

This is different from approaches applied to nearly all other risk evaluations in medicine (eg NSTEMI, A-fib)
3/The top-line recommendations lacked sufficient & explicit top-line recognition of the need to decide on care based on knowledge of overall patient life and functioning.

Note: DEA is investigating & prosecuting from the same narrow viewpoint
4/Urine drug testing and 3-day limits created brightline regulatory and legal targets (as indeed happened), but were tethered to modest data (the initial Rx duration actually IS associated with continued receipt, if one recognizes the limitations of that data)
5/The reason for concern at the time was the expectation, denied by the text of the Guideline itself, that the numeric thresholds would be given “regulatory force”.

Today, payers, Medicare, OIG and DEA agents use the Guideline that way. Reasons for hope ?
6/First the Guideline is being rewritten and the experts advising the CDC include members of the affected communities like @speakingabtpain , experts who have stuck their neck out for patients like @BethDarnall and others I deeply respect. They are clear cdc.gov/injury/pdfs/bs…
7/it is now accepted: with opioid Rx/capita at the level of 1992..

what sustains our crisis is *not what started it*

I wrote that line in late 2016 for “Turning the Tide or Riptide” - which became the most downloaded in the history of @SubstanceAbuseJ

tandfonline.com/doi/full/10.10…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Stefan Kertesz, MD

Stefan Kertesz, MD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @StefanKertesz

22 Nov
1/Suicides that follow prescription opioid reduction are a tragedy we need to discuss openly, and mainstream reporters almost never do.

This article by @DrewQJoseph is commendable.

Our work to learn from families who have suffered these losses is linked in the next tweet
2/Our team at @UABNews has been running a preliminary version of a larger planned study, a survey to reach family survivors to learn about these tragedies one by one, like safety investigators would an airplane crash. We think that is the place to start. It is called CSI:OPIOIDs Image
3/As a clinician, I have been advocating to address these losses since 2016.

In 2018, I began urging federal study of the individual suicides, because large database statistics, concerning as they are, don’t reveal the circumstances around losses. We have to look closely.
Read 8 tweets
14 Nov
@Jinxthejjinx @ChadDKollas @OregonAdvocate @PainMedJournal @LabGirl_Chloe @supportprop 1/I see this paper as direct, and not one that is terribly supportive of tapering policies (and it's good to report this): it's clear from this report that taper often fails, and that switch to buprenorphine helps some, and at least as often fails with others.
@Jinxthejjinx @ChadDKollas @OregonAdvocate @PainMedJournal @LabGirl_Chloe @supportprop 2/Here, in the paper we see that when high dose patients are referred, 36% leave before or after taper initiation. Wait for the pain results, next This is a chart showing 801 patients with opioid receipt wer
@Jinxthejjinx @ChadDKollas @OregonAdvocate @PainMedJournal @LabGirl_Chloe @supportprop 3/Here it says that among the subset of 89 who got all the way below 90 MME, the majority (52%) had ⬆️ of pain, but 24% had no change and 24% had ⬇️ of pain. This means that taper may help some pain, but more often it does the opposite. That's the data.
Read 9 tweets
13 Nov
1/This is a sobering, important article, with devastating observations from a formerly homeless Veteran. Mailing medication to someone who is homeless? Yikes.

Let’s learn from the unfavorable experiences.

(Research on that in next tweet)
2/Our research finds that persons who are homeless, Veteran or not, are often subject to misunderstanding or stigma, and that aspirations for what makes care good are not interchangeable with mainstream concepts - @AllysonVarley journals.sagepub.com/doi/abs/10.117…
3/In large VA-funded research studies. we find that intentional efforts to tailor the design & delivery of primary care for persons experiencing homelessness, prevents unfavorable experiences in care! journals.lww.com/lww-medicalcar…
Read 5 tweets
11 Nov
1/Listening to @1a "Against the Pain" - @1a is to be commented for covering this issue Hats off.

I wish to share a thought on a form of bias built into NARXCare as it is obvious, correctable, and harms patients.
wamu.org/story/21/11/11…
2/Dr. Nishi Rawat of Bamboo Health (provider of the NARXCare algorithm to assess overdose risk) describes the NARXCare product they put onto the screens of doctors (via Prescription Drug Monitoring Programs) as an "objective summary". About that...
3/Dr. Rawat's definition of NARXCare covers 2 distinct function. One is a graphic summary of the Rx's received by a patient (if the data are accurate, this is helpful).
But the concerning one is an "Overdose Risk Score"
Read 16 tweets
4 Nov
1/Join us for "Research to Measure What Matters in Primary Care for Persons Experiencing Homelessness: What's the Point, Really?"

@HarvardChanSPH Initiative on Health & Homelessness
Register online for our event Wed 11/10, 1pm EST
Let me offer a brief 🧵:
2/I began focusing on homeless patients' views of care after working in Boston's shelters.

"Wow!" I thought "much of what we do we doesn't look good with traditional ways of measuring quality of care!"

My co-presenter Dr. Roncarati has >15 yrs with the @BHCHP Street Team
3/Standard quality of care metrics (visit counts, blood pressure checks) seem good

but what if what we homeless health clinicians *really focus on* is:

"Spending hours to build trust with a person who has been traumatized by repeated bad experiences in health care?"?
Read 9 tweets
3 Nov
1/It is bad that clinician performance on matters related to the opioid crisis is *still* being measured in terms of # of opioid prescriptions.
These metrics, which ape prior metrics that drove the original⬆️ reject the approach we normally require for measuring quality of care
2. To be clear. Optimal health care metrics require
a) clear denominator of eligible patients with the condition
b) clear evidence that the treatment's provision is wholly good or its nonprovision wholly bad
c)evidence that imposing the metric leads to improvements in health
3. For example, a metric such as "provision of cervical cancer screening" would be BAD if it includes persons with no cervix either because of hysterectomy, or because they are cis-male.
Read 11 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(